首页
>>
产品中心
>>
抗体产品
>>
重组抗体
>
Anti-Human IFNG Recombinant Antibody(Fontolizumab)

Anti-Human IFNG Recombinant Antibody(Fontolizumab)

产品编号

YR1022

别名

科研级 Fontolizumab ( 芳妥珠单抗 ), Anti-IFNG Recombinant Antibody, Research Grade Fontolizumab

规格
  • 1mg
  • 5mg
产品介绍
Alias科研级 Fontolizumab ( 芳妥珠单抗 ), Anti-IFNG Recombinant Antibody, Research Grade Fontolizumab
Catalog NumberYR1022
Molecular NameFontolizumab
Size1mg, 5mg
ClonityMonoclonal
Purity>95% as determined by SDS-PAGE
Concentration1mg/ml
Antibody IsotypeIgG1
FormulationPBS, pH7.5
BackgroundFontolizumab (planned trade name HuZAF) is a humanized monoclonal antibody and an immunosuppressive drug for the treatment of auto-immune diseases like Crohn's disease. A phase II clinical trial investigating the use for rheumatoid arthritis was terminated because the first phase did not meet the endpoint.
CAS Number326859-36-3
ApplicationIF, IP, Neut, FuncS, ELISA, FCM, ICC, Activ, WB
Storage ConditionIt is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
RemarksThis product is for research use only.
Shipping ConditionShipped on ice packs.
TargetIFNG[Homo sapiens]

登录

还没有账号?立即注册

注册

已有账号?立即登录

立即询价